Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.2360
+0.1610
+(14.98%)
At close: February 21 at 5:32:30 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-75,830
-70,828
-65,144
-83,233
-46,124
Investing Cash Flow
-426
9,462
-9,741
-67
-146
Financing Cash Flow
75,068
1,033
95,760
42,841
144,431
End Cash Position
58,501
46,674
106,745
86,863
127,452
Capital Expenditure
-426
-334
-112
-67
-146
Issuance of Capital Stock
762
853
95,573
42,749
144,431
Free Cash Flow
-76,256
-71,162
-65,256
-83,300
-46,270
12/31/2020 - 4/25/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
96X.F FluoGuide A/S
3.7550
-6.24%
NV4.F Cellectar Biosciences, Inc.
0.2600
-23.53%
RGO.DU Regeneron Pharmaceuticals Inc
657.40
+1.20%
600161.SS TIANTAN BIO
20.05
-0.35%
PH4.F CStone Pharmaceuticals
0.3720
+4.49%
HQ1.MU Oruka Therapeutics Inc. R
10.60
+0.95%
GYX.F Futura Medical plc
0.1770
+14.94%
BSSP Baseline Productions, Inc.
0.0001
0.00%
22UA.DU BioNTech SE
114.70
+2.59%
2563.HK Beijing Biostar Pharms Co Ltd
17.680
-1.78%